Femme et Homme
- | Pays :
- Canada
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to test the potential antiviral efficacy of triple-combination therapy with Peginterferon α-2b + ribavirin + boceprevir (PRB) in patients with HCV genotype 3 who previously failed Peginterferon α + ribavirin (non-responders or relapsers).
Critère d'inclusion
- Hepatitis C